Saroja Pharma Industries India Ltd vs Tgv Sraac Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Saroja Pharma Industries India Ltd is ₹ 28.15 as of 23 Mar 15:30 . The P/E Ratio of Saroja Pharma Industries India Ltd changed from 16.1 on March 2024 to 14.7 on March 2025 . This represents a CAGR of -4.45% over 2 yearsThe P/E Ratio of TGV Sraac Ltd changed from 9 on March 2021 to 11 on March 2025 . This represents a CAGR of 4.10% over 5 years The Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 14.11 crore on March 2024 to ₹ 15.18 crore on March 2025 . This represents a CAGR of 3.72% over 2 yearsThe Market Cap of TGV Sraac Ltd changed from ₹ 259.69 crore on March 2021 to ₹ 1016 crore on March 2025 . This represents a CAGR of 31.37% over 5 years The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of TGV Sraac Ltd for the Dec '25 is ₹ 454.41 crore as compare to the Sep '25 revenue of ₹ 503.18 crore. This represent the decline of -9.69% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of TGV Sraac Ltd for the Dec '25 is ₹ 83.59 crore as compare to the Sep '25 ebitda of ₹ 96.16 crore. This represent the decline of -13.07% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of TGV Sraac Ltd changed from ₹ 13.71 crore to ₹ 28.1 crore over 7 quarters. This represents a CAGR of 50.69% The Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of TGV Sraac Ltd changed from 2.96 % on March 2023 to 11.63 % on March 2025 . This represents a CAGR of 57.80% over 3 years .

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

About TGV Sraac Ltd

TGV Sraac Limited, formerly known as Sree Rayalaseema Alkali and Allied Chemicals Limited was incorporated on 24th June, 1981.
The name of Company was changed from 'Sree Rayalaseema Alkali and Allied Chemicals Limited' to 'TGV Sraac Limited' in September, 2017.
Company is the leading producer of Chlor'Alkali Chemicals, Chloromethanes and also manufactures Castor Derivatives and Fatty Acids.
It manufactures Caustic Soda, Liquid Chlorine, Hydrochloric Acid, Hydrogen and Barium Sulphate. The company started commercial production in Aug.'88 with an initial installed capacity of 22,440 tpa of caustic soda.
Presently the company has the capacity to produce 69500 TPA of caustic soda The company uses Bipolar Membrane Cell Technology, the latest one in the world for the manufacture of caustic soda and allied products.

FAQs for the comparison of Saroja Pharma Industries India Ltd and TGV Sraac Ltd

Which company has a larger market capitalization, Saroja Pharma Industries India Ltd or TGV Sraac Ltd?

Market cap of Saroja Pharma Industries India Ltd is 11 Cr while Market cap of TGV Sraac Ltd is 886 Cr

What are the key factors driving the stock performance of Saroja Pharma Industries India Ltd and TGV Sraac Ltd?

The stock performance of Saroja Pharma Industries India Ltd and TGV Sraac Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Saroja Pharma Industries India Ltd and TGV Sraac Ltd?

As of March 23, 2026, the Saroja Pharma Industries India Ltd stock price is INR ₹28.15. On the other hand, TGV Sraac Ltd stock price is INR ₹82.74.

How do dividend payouts of Saroja Pharma Industries India Ltd and TGV Sraac Ltd compare?

To compare the dividend payouts of Saroja Pharma Industries India Ltd and TGV Sraac Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.